Pasithea Therapeutics Cor... (KTTA)
NASDAQ: KTTA
· Real-Time Price · USD
0.71
0.01 (1.04%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.49%
After-hours: Aug 15, 2025, 07:51 PM EDT
Pasithea Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.56B | -3.18M | -3M | -3.87M | -3.86M | -5.03M | -3.61M | -3.6M | -3.27M | -5.12M | -4.19M | -2.66M | -1.57M | 630.12K | -1.53M | -727.95K | -549.61K |
Depreciation & Amortization | 4.17M | 162.26K | 162.26K | 162.26K | 162.26K | 162.22K | 162.26K | 162.26K | 161.72K | -97 | n/a | 10.79K | 5.01K | 1.38K | n/a | n/a | n/a |
Stock-Based Compensation | 98.56M | 118.38K | 147.88K | 160.95K | 346.48K | 69.94K | 126.67K | 218.63K | 177.02K | 156.17K | -16.07K | 559.33K | 135.63K | 156.59K | 15K | n/a | n/a |
Other Working Capital | n/a | 1.97M | -501.06K | -531.45K | -942.26K | 1.45M | 129.85K | 315.04K | 33.85M | -830.61M | -1.16M | 132.95K | -294.99K | -354.18K | n/a | n/a | n/a |
Other Non-Cash Items | n/a | -1.41K | 70.31K | 35.62K | 644.28K | 429.91K | 960.00 | 960.00 | 47.83K | -482.79K | 1.41M | -421.7K | -785.3K | -32.51K | 1.32M | 16.8K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -394.38K | 538.14K | -578.16K | n/a | n/a | n/a | n/a | n/a | -2.59M | n/a | n/a | n/a |
Change in Working Capital | n/a | 1.97M | -501.06K | -531.45K | -942.26K | 1.45M | 129.85K | 315.04K | -323.04K | 1.03M | -749.8K | 132.95K | -308.58K | 86.49K | -354.73K | 211.7K | 167.76K |
Operating Cash Flow | -3.06B | -2.44M | -3.12M | -4.04M | -4.32M | -3.31M | -2.65M | -3.48M | -3.2M | -4.42M | -4.22M | -2.38M | -2.53M | -1.74M | -548.44K | -499.44K | -381.85K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 36.00 | 22.66K | -3.11K | -53.89K | -1.79M | -5.49K | -38.31K | -113.87K | -12.93K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 54.5K | 27.5K | 27.5K | n/a | 32.98K | -20.48K | 77.06K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 54.5K | 27.5K | 319.62K | -4.19K | 1.1M | -1.19M | -538.84K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 54.54K | 50.16K | 344.01K | -53.89K | -1.76M | -185.92K | 38.75K | -113.87K | -12.93K | -8.57K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -133.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -3.72B | -3.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -178.44M | -23.55K | 4.54M | n/a | n/a | n/a | n/a | -130.77K | 264.1K | -3.21M | -1.03M | 106.54K | n/a | 7M | -1.31M | n/a | n/a |
Financial Cash Flow | 1.47B | -23.55K | 4.54M | n/a | n/a | -16.89K | -4.45M | -130.77K | 264.1K | -3.21M | -1.03M | 106.54K | n/a | 34.17M | 20.55M | n/a | 1.21M |
Net Cash Flow | -1.58B | -2.44M | 1.39M | -4.04M | -4.32M | -3.25M | -7.06M | -3.27M | -3.17M | -9.25M | -5.52M | -2.38M | -2.65M | 32.4M | 20M | -501.75K | 827.08K |
Free Cash Flow | -3.06B | -2.44M | -3.12M | -4.04M | -4.32M | -3.31M | -2.63M | -3.48M | -3.26M | -6.21M | -4.23M | -2.42M | -2.64M | -1.76M | -548.44K | -499.44K | -381.85K |